TBAP-001
TBAP-001 (Synthesis 13), extracted from patent WO2015075483A1, is a pan-RAF kinase inhibitor, with an IC50 of 62 nM in BRAF V600E kinase assay[1].
Product Specifications
CAS Number
1777832-90-2
UNSPSC
12352005
Target
Raf
Type
Reference compound
Related Pathways
MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/tbap-001.html
Concentration
10mM
Purity
99.81
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
O=C(NC1=CC(C(C)(C)C)=NN1C2=CC=CC(F)=C2)NC3=CC=C(OC4=C(N=C5)C(NC5=O)=NC=C4)C=C3F
Molecular Formula
C27H23F2N7O3
Molecular Weight
531.51
References & Citations
[1]Caroline Joy, et al. 1 - (5-TERT-BUTYL-2-ARYL-PYRAZOL-3-YL) -3-[2-FLUORO-4-[ (3-OXO-4H-PYRIDO[2
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY426541 100 µg
FAM178B (NM_001122646) Human Over-expression Lysate
Sign In for Pricing
View Details 
BNC473059-500 1x 500 µL
Cyclin B2 (X29.2), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 